Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Phillip H. Lam"'
Autor:
Charles O. Faselis, Gregg C. Fonarow, Farooq H. Sheikh, Shalini D. Allam, Prakash Deedwania, Cherinne Arundel, Ali Ahmed, Wilbert S. Aronow, Poonam Bhyan, Venkatesh K. Raman, Phillip H. Lam, Samir S. Patel, Ioannis Kanonidis, Richard M. Allman, Apostolos Tsimploulis
Publikováno v:
The American Journal of Medicine. 135:737-744
Background In patients with heart failure with reduced ejection fraction (HFrEF) and hypertension, systolic blood pressure is recommended to be maintained below 130 mmHg, although this has not been shown to be associated with improved outcomes. We ex
Autor:
Charles Faselis, Richard M. Allman, Helen Sheriff, Robert Enders, Essraa Bayoumi, Phillip H. Lam, Ali Ahmed, Cherinne Arundel, Prakash Deedwania, Vijaywant Brar, Gregg C. Fonarow, Corrine Y Jurgens
Publikováno v:
The American Journal of Medicine. 135:607-614
Background: Beta-blockers improve clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF). Less is known about their role in older nursing home residents with HFrEF. Methods: From the combined OPTIMIZE-HF and Alabama H
Autor:
Gerasimos Filippatos, Brandon George, Kalliopi Keramida, Charity J. Morgan, Gaurav Choudhary, Neha Gupta, Ami E. Iskandrian, Wen-Chih Wu, Prakash Deedwania, Ali Ahmed, Gregg C. Fonarow, John G.F. Cleland, Charles Faselis, Phillip H. Lam
Publikováno v:
Journal of Cardiac Failure. 28:65-70
Background A low right ventricular ejection fraction (RVEF) is a marker of poor outcomes in patients with heart failure with reduced ejection fraction (HFrEF). Beta-blockers improve outcomes in HFrEF, but whether this effect is modified by RVEF is un
Autor:
Charity J. Morgan, Hans Moore, Markus S. Anker, Cherinne Arundel, Prakash Deedwania, Richard M. Allman, Samuel Wopperer, Steven N. Singh, Charles Faselis, Gregg C. Fonarow, Qing Zeng, Phillip H. Lam, Lakshmi Tummala, Pamela Karasik, Ali Ahmed
Publikováno v:
The American Journal of Medicine. 133:1460-1470
Background Digoxin reduces the risk of heart failure hospitalization but has no effect on mortality in patients with heart failure without atrial fibrillation in the randomized controlled trial setting. Observational studies of digoxin use in patient
Autor:
Cherinne Arundel, Milton Packer, Steven N. Singh, Yan Cheng, Wayne C. Levy, Richard M. Allman, Vijaywant Brar, Wen-Chih Wu, Gregg C. Fonarow, Phillip H. Lam, Michael R. Zile, Ali Ahmed, Gauravpal S. Gill
Publikováno v:
The American Journal of Medicine. 133:1187-1194
Background Digoxin reduces the risk of heart failure hospitalization in patients with heart failure with reduced ejection fraction. Less is known about this association in patients with heart failure with preserved ejection fraction (HFpEF), the exam
Autor:
Bertram Pitt, Prakash Deedwania, Gregg C. Fonarow, Ali Ahmed, Charity J. Morgan, Deepak L. Bhatt, Neha Gupta, Steven N. Singh, Michael R. Zile, Phillip H. Lam, Daniel J. Dooley
Publikováno v:
The American Journal of Medicine. 131:1473-1481
Background Beta-blockers in high target doses are recommended for heart failure with reduced ejection fraction (HFrEF) but not for preserved ejection fraction (HFpEF). Treatment benefits are often more pronounced in high-risk subgroups, and patients
Autor:
Cherinne Arundel, Wilbert S. Aronow, Helen Sheriff, Ali Ahmed, Gregg C. Fonarow, Richard M. Allman, Finn Waagstein, Poonam Bhyan, Phillip H. Lam, Charity J. Morgan, Daniel J. Dooley, Selma F. Mohammed
Publikováno v:
Clinical Cardiology. 41:406-412
BACKGROUND: Digoxin use has been associated with a lower risk of 30‐day all‐cause admission and readmission in patients with heart failure and reduced ejection fraction (HFrEF). HYPOTHESIS: Digoxin use will be associated with improved outcomes in
Autor:
Marc R. Blackman, Stefan D. Anker, Wilbert S. Aronow, Daniel E. Forman, Inmaculada Aban, Javed Butler, Ioannis Kanonidis, Phillip H. Lam, Deepak L. Bhatt, Prakash Deedwania, Chris Adamopoulos, Daniel J. Dooley, Gerasimos Filippatos, Bertram Pitt, Ross D. Fletcher, Gregg C. Fonarow, Kanan Patel, Michel White, Richard M. Allman, Cherinne Arundel, Ali Ahmed
Publikováno v:
European Journal of Heart Failure. 20:359-369
Aims To examine associations of below-target and target dose of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, with outcomes in patients with heart failure and reduced ejection fraction (HFrEF) in the Studies of Left Ventricular Dysfunc
Publikováno v:
Heart Failure Clinics. 13:581-587
Heart failure is a disease of poor prognosis marked by frequent hospitalizations, premature death, and impaired quality of life. Despite advances in medical therapy for patients with heart failure and reduced ejection fraction, mortality and hospital
Autor:
Phillip H. Lam, Bertram Pitt, Gregg C. Fonarow, Richard M. Allman, Charles Faselis, Steven N. Singh, Milton Packer, Charity J. Morgan, Ali Ahmed
Publikováno v:
The American journal of medicine. 133(2)
Background In the Studies of Left Ventricular Dysfunction (SOLVD) treatment trial, similar clinical benefits were observed between starting doses of enalapril and the target dose achieved by postrandomization up-titration. In our current analysis, pr